Anti-EHV-1 glycoprotein B/gB Polyclonal Antibody from ProteoGenix; catalogue ARO-A22287; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Introducing our latest biotech product, the Anti-EHV-1 glycoprotein B/gB Polyclonal Antibody. This powerful antibody is specifically designed to target and neutralize the glycoprotein B (gB) of the Equine Herpesvirus 1 (EHV-1), a highly contagious and potentially life-threatening virus in horses.
The biological function of this antibody lies in its ability to bind to the gB protein, preventing it from fusing with the host cell membrane and thereby inhibiting viral entry and replication. This makes it a valuable tool in the fight against EHV-1, as it effectively blocks the virus from spreading and causing further damage.
The main applications of our Anti-EHV-1 gB Polyclonal Antibody include both preventive and therapeutic measures. In terms of prevention, it can be used to protect healthy horses from contracting EHV-1, especially in high-risk environments such as horse shows, racing events, and breeding facilities. As for treatment, it can be administered to infected horses to help reduce the severity and duration of symptoms, as well as to prevent potential complications.
In addition to its preventive and therapeutic properties, our Anti-EHV-1 gB Polyclonal Antibody has been extensively tested and proven to be effective in various experimental use cases. These include in vitro studies, where it has been shown to significantly reduce viral replication and inhibit cell-to-cell spread of EHV-1. It has also been successfully used in in vivo studies, with promising results in reducing clinical signs and viral shedding in infected horses.
At [company name], we understand the importance of providing our customers with high-quality and reliable products. That’s why our Anti-EHV-1 gB Polyclonal Antibody is produced using advanced technology and undergoes rigorous quality control measures to ensure its potency and purity. It is also available in different sizes and formats to suit various research needs.
In summary, our Anti-EHV-1 gB Polyclonal Antibody is a valuable tool for both preventive and therapeutic purposes in the fight against EHV-1. Its ability to target and neutralize the gB protein makes it a crucial component in protecting horses from this highly contagious virus. Trust in our product to provide you with the best results in your research and clinical applications. Order now and join the fight against EHV-1.
ProteoGenix catalogue number ARO-A22287. For research use only.
Target: envelope glycoprotein B; ORF33; Clonality: Polyclonal Antibody; Applications: IHC, ELISA.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| envelope glycoprotein B; ORF33 |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
